Sign in

CIK 0000715446

  • Non-accelerated filer
  • Smaller reporting company

Anixa Biosciences Inc

Sign in to watch
Ticker
ANIX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Oct 31
Incorporated
DE
Entity type
Operating
EIN
112622630
Phone
+1 408-708-9808
Business address
3150 ALMADEN EXPRESSWAY, SUITE 250, SAN JOSE, CA, 95118
Former names
ITUS Corp, COPYTELE INC
  1. 4 Open-market buy Chief Executive Officer bought 5,000 shares at $4.86 ($24,300)
  2. 4 Gift Director gave 200,000 shares (gift)
  3. 4 Open-market buy Chief Executive Officer bought 10,000 shares at $3.73 ($37,300)
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Other acquisition COO & CFO acquired 1,918 shares (other)
  7. 4 Open-market buy Director bought 40,000 shares at $2.08 ($83,200)
  8. 4 Open-market buy Chief Executive Officer bought 28,000 shares at $2.11 ($59,080)
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Open-market buy Director bought 24,500 shares at $2.27 ($55,615)
  15. 4 Open-market buy Director bought 31,083 shares at $2.27 ($70,558)
  16. 4 Open-market buy Chief Executive Officer bought 20,000 shares at $2.03 ($40,600)
  17. 4 Other acquisition COO & CFO acquired 1,867 shares (other)
  18. 4 Open-market buy Director bought 5,799 shares at $2.12 ($12,294)
  19. 4 Open-market buy Director bought 10,000 shares at $1.84 ($18,400)
  20. 4 Open-market buy Chief Executive Officer bought 20,000 shares at $1.82 ($36,400)

Page 7 of 24 · 471 filings